William Wesley Marshall—Sale of Privately Issued Preferred Stock without Prior Notice

Rochester stockbroker fraud attorneyWilliam Wesley Marshall, Med School Grad, Allegedly Participated in the Sale of $1.72 Million of Privately Issued Preferred Stock without Providing Prior Written Notice to His Broker-Dealer Ameriprise

William Wesley Marshall, from from January 6, 2011 through May 2, 2012, allegedly participated in the sale of $1.72 million of privately issued preferred stock without having provided prior written notice to Ameriprise, according to a recent FINRA Letter of Acceptance, Waiver and Consent (AWC)currently under review by attorneys Alan Rosca and Joe Peiffer.

Marshall, a med school grad taken on by Ameriprise Financial Services, Inc. as a registered rep, allegedly received common stock purchase warrants from the issuer, BioChemics Inc. as compensation for facilitating certain private securities transactions, said AWC notes.

The Peiffer Rosca Wolf securities lawyers are currently investigating William Wesley Marshall’s alleged participation in the sale of privately issued preferred stock without having provided prior written notice.

William Wesley Marshall Allegedly Used an Unapproved Personal E-mail Account to Communicate with BioMedics Customers, Distributed Sales Literature Prepared by BioChemics to Investors that Failed to Disclose Business and Personal Financial Interest in BioChemics; Suspended by FINRA and Fined $10K

William Wesley Marshall allegedly used an unapproved personal e-mail account to communicate with firm customers about investing in BioChemics and distributed sales literature prepared by BioChemics to investors that purportedly failed to disclose his business and personal financial interest in BioChemics, according to the aforementioned AWC presently being reviewed by attorneys Alan Rosca and Joe Peiffer.

Marshall also purportedly served as a member of BioChemics’ Scientific Advisory Board during his association with the firm, and received common stock purchase warrants from BioChemics as compensation, the AWC notes.

Finally, as a result of the aforementioned behavior, Marshall allegedly violated FINRA and NASD Rules and has been suspended for fifteen months by FINRA and fined $10K. One should also note that, according to the AWC, William Wesley Marshall neither admitted nor denied the FINRA findings.

The Peiffer Rosca Wolf Securities Lawyers Often Assist Investors

The Peiffer Rosca Wolf securities lawyers assist investors who lose money as a result of alleged participation in the sale of privately issued preferred stock without having provided prior written notice, and are currently investigating William Wesley Marshall . They take most cases of this type on a contingency fee basis and advance the case costs, and only get paid for their fees and costs out of money they recover for their clients.

Investors who believe they lost money as a result of sale of privately issued preferred stock without having provided prior written notice are encouraged to contact the securities lawyers at Peiffer Rosca Wolf, Alan Rosca or Joe Peiffer, for a free, no-obligation evaluation of their recovery options, at 888-998-0520.

Alan Rosca (1144 Posts)

Alan is a securities lawyer. He also teaches Securities Regulation at the Cleveland-Marshall College of Law. He focuses his legal practice on complex commercial and financial litigation and arbitration, particularly in the areas of securities and investment fraud. His office is in Cleveland, Ohio.


In our legal system, every person is innocent until and unless found guilty by a court of law or a tribunal. Whenever we reference “allegations” or charges that are “alleged,” such allegations or charges have not been proven, and are merely accusations, not findings of fault, as of the date of the blog. We do not have, nor do we undertake, a duty to continue to monitor or follow cases about which we report, and/or to publish subsequent blogs regarding various developments that may occur in such cases. Readers are encouraged to conduct their own research regarding any such cases and any developments that may or may not have occurred in such cases.